Pharmacokinetics News and Research

RSS

The term pharmacokinetics is derived from the ancient Greek words “pharmakon” and “kinetikos”, meaning “drug” and “putting in motion” respectively. It is one of the main branches of pharmacology, and refers to the way that the body reacts on and affects a pharmaceutical substance in the body.

New system personalizes chemotherapy doses for cancer patients

When cancer patients undergo chemotherapy, the dose of most drugs is calculated based on the patient's body surface area. This is estimated by plugging the patient's height and weight into an equation, dating to 1916, that was formulated from data on just nine patients.

24 Apr 2024

Breakthrough imaging method enhances precision in prostate cancer treatment

A novel SPECT/CT acquisition method can accurately detect radiopharmaceutical biodistribution in a convenient manner for prostate cancer patients, opening the door for more personalized treatment.

17 Apr 2024

Insilico Medicine's AI-driven approach yields promising PTPN2/N1 inhibitor for cancer immunotherapy

In recent years, cancer immunotherapy, exemplified by PD-1 and its ligand PD-L1 blockade, has made remarkable advances.

13 Apr 2024

UC researchers open Phase 2 clinical trial to test new combination treatment for glioblastomas

A multidisciplinary team of University of Cincinnati Cancer Center researchers have opened a Phase 2 clinical trial to test a new combination treatment for glioblastomas (GBM), the most deadly form of brain tumors.

26 Mar 2024

Rising antimicrobial resistance in STIs: A call for global action

Review delves into the rising challenge of antimicrobial resistance in sexually transmitted infections, underscoring the need for innovative treatments and the critical role of global surveillance in managing diseases like gonorrhea and syphilis.

21 Mar 2024

Aston University and Catalent develop faster medicine formulation process

A partnership between Aston University and contract medicine manufacturer Catalent has led to a faster process to identify the best ingredients for optimal medicine formulations, and has been rated as outstanding by Innovate UK.

19 Mar 2024

Nanoparticles turbocharge turmeric's curcumin for enhanced health benefits

Study explores nanoparticle-enhanced curcumin formulations, promising to significantly boost its health benefits including anticancer, antioxidant, and anti-inflammatory effects by improving bioavailability and bioactivity.

17 Mar 2024

New hope for binge eating and bulimia: GLP-1 drugs could be the key

GLP-1 receptor agonists show promise in reducing binge eating behaviors in disorders like bulimia nervosa, offering a new avenue for treatment with minimal side effects.

4 Mar 2024

Research validates concurrent use of HIV medications and gender-affirming hormone therapy

New research definitively shows that HIV antiretrovirals can be taken together with gender-affirming hormone therapy without changing how well either drug works.

4 Mar 2024

Optibrium launches a metabolism prediction software platform tailored to DMPK scientists

Semeta™ offers high sensitivity and superior precision for the prediction of Phase I and II metabolic routes, sites, products and liabilities in early drug discove.ry

From Optibrium Ltd. 27 Feb 2024

UH researcher aims to revolutionize treatment regimens for triple-negative breast cancer

A researcher at the University of Houston College of Pharmacy Drug Discovery Institute is working to revolutionize treatment regimens for triple-negative breast cancer (TNBC) by proving that nebivolol, an FDA-approved drug for high blood pressure, is effective in treating it.

31 Jan 2024

Subcutaneous nivolumab revolutionizes renal cell carcinoma care with faster, easier treatment

Subcutaneous injection of the immunotherapy nivolumab (brand name Opdivo) is noninferior to intravenous delivery and dramatically reduces treatment time in patients with renal cell carcinoma, as seen in the results of a large phase 3 clinical trial reported today at the 2024 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium in San Francisco, California.

29 Jan 2024

CN Bio and Altis Biosystems partner to develop next-generation human Gut/Liver in vitro model for advanced ADME studies

CN Bio and Altis Biosystems, Inc. (“Altis”), leading developers of in vitro human organ models that optimize the accuracy and efficiency of drug development, today announced a strategic partnership.

24 Jan 2024

CN Bio and Altis Biosystems partner to develop next-generation human Gut/Liver in vitro model for advanced ADME studies

...

From CN-Bio 23 Jan 2024

What is the association between prenatal opioid exposure and risk of immune-related conditions?

Researchers compared the risk of hospitalization and emergency department presentation for immune-related conditions in children with and without prenatal opioid exposure.

19 Jan 2024

Promising PET scanner tool developed for rare medullary thyroid cancer

A newly developed PET imaging agent has been found to be effective in identifying medullary thyroid cancer (MTC) in preclinical and clinical studies, according to research published in the January issue of The Journal of Nuclear Medicine.

11 Jan 2024

Ginseng's hidden gems: Rare ginsenosides emerge as potent players in the future of medicine

Review in the Journal of Advanced Research summarizes the properties, applications, and production of rare ginsenosides (RGs), highlighting their potential in treating various diseases including cancer and cardiovascular ailments.

8 Jan 2024

$15 million NCI grant awarded to investigate a type of radiation therapy for hard-to-treat cancers

The Radiopharmaceutical Therapy and Dosimetry Lab at Johns Hopkins Medicine, headed by George Sgouros, Ph.D., has been awarded a $15 million grant, to be dispersed over the next five years, from the National Cancer Institute at the National Institutes of Health.

28 Dec 2023

Degron Therapeutics announced as winner of AFCR's 2023 BRACE Award Venture Competition

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition.

27 Dec 2023

AI-driven advancements in electronic skin technology promise revolution in health monitoring and diagnostics

Review discusses the integration of AI in developing next-generation e-skin, focusing on engineering challenges, signal processing, and health data analysis for applications in human-machine interfaces and disease diagnosis.

19 Dec 2023

Pharmacokinetics News and Research

Further Reading

New system personalizes chemotherapy doses for cancer patients

Breakthrough imaging method enhances precision in prostate cancer treatment

Insilico Medicine's AI-driven approach yields promising PTPN2/N1 inhibitor for cancer immunotherapy

UC researchers open Phase 2 clinical trial to test new combination treatment for glioblastomas

Rising antimicrobial resistance in STIs: A call for global action

Aston University and Catalent develop faster medicine formulation process

Nanoparticles turbocharge turmeric's curcumin for enhanced health benefits

New hope for binge eating and bulimia: GLP-1 drugs could be the key

Research validates concurrent use of HIV medications and gender-affirming hormone therapy

Optibrium launches a metabolism prediction software platform tailored to DMPK scientists

UH researcher aims to revolutionize treatment regimens for triple-negative breast cancer

Subcutaneous nivolumab revolutionizes renal cell carcinoma care with faster, easier treatment

CN Bio and Altis Biosystems partner to develop next-generation human Gut/Liver in vitro model for advanced ADME studies

CN Bio and Altis Biosystems partner to develop next-generation human Gut/Liver in vitro model for advanced ADME studies

What is the association between prenatal opioid exposure and risk of immune-related conditions?

Promising PET scanner tool developed for rare medullary thyroid cancer

Ginseng's hidden gems: Rare ginsenosides emerge as potent players in the future of medicine

$15 million NCI grant awarded to investigate a type of radiation therapy for hard-to-treat cancers

Degron Therapeutics announced as winner of AFCR's 2023 BRACE Award Venture Competition

AI-driven advancements in electronic skin technology promise revolution in health monitoring and diagnostics

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News